NCT00957411 2025-11-24
CETUXICOL
Institut Curie
Phase 2 Completed
Clinical Trials
10 trialsNCT00766142 2025-08-29
COCHISE
Institut Bergonié
Phase 2 Terminated
NCT00997009 2023-11-14
MITO CERV 2
National Cancer Institute, Naples
Phase 2 Unknown
NCT00101192 2014-03-17
Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
GOG Foundation
Phase 2 Completed
NCT00086892 2014-02-14
Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
GOG Foundation
Phase 2 Completed
NCT00392769 2012-09-06
Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00518193 2011-06-30
ERBUS
ARCAGY/ GINECO GROUP
Phase 2 Terminated
NCT00292955 2011-05-30
Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma
University of Virginia
Phase 2 Unknown
NCT00082212 2010-04-09
A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma
Eli Lilly and Company
Phase 2 Terminated
NCT00063401 2010-04-08
Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Eli Lilly and Company
Phase 2 Completed